F Montemurro Selected Research

Inflammation (Inflammations)

12/2014

Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Montemurro Research Topics

Disease

22	Breast Neoplasms (Breast Cancer) 10/2022 - 10/2000
9	Neoplasms (Cancer) 01/2021 - 12/2001
3	Brain Neoplasms (Brain Tumor) 01/2021 - 07/2015
2	Triple Negative Breast Neoplasms 12/2023 - 01/2021
1	Neutropenia 01/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 12/2015
1	Necrosis 12/2014
1	Inflammation (Inflammations) 12/2014
1	Disease Progression 06/2012
1	Stomach Neoplasms (Stomach Cancer) 08/2007
1	Prostatic Neoplasms (Prostate Cancer) 01/2006
1	Neoplasm Metastasis (Metastasis) 02/2004
1	Hodgkin Disease (Hodgkin's Disease) 01/2000

Drug/Important Bio-Agent (IBA)

6	Hormones (Hormone)IBA 01/2021 - 05/2002
6	Trastuzumab (Herceptin)FDA Link 01/2021 - 04/2005
4	human ERBB2 proteinIBA 10/2022 - 11/2013
3	Ado-Trastuzumab EmtansineIBA 10/2022 - 10/2020
3	Aromatase InhibitorsIBA 10/2020 - 11/2006
2	exemestane (Aromasin)FDA Link 10/2020 - 01/2016
2	Everolimus FDA Link 10/2020 - 01/2016
2	Etoposide (VP 16)FDA LinkGeneric 04/2018 - 08/2007
2	Lapatinib (GW572016)FDA Link 07/2015 - 06/2012
2	Capecitabine (Xeloda)FDA Link 07/2015 - 06/2012
2	Phenobarbital (Luminal)FDA Link 12/2014 - 10/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 12/2014 - 11/2006
2	Fluorouracil (Carac)FDA LinkGeneric 08/2007 - 02/2006
1	Immune Checkpoint InhibitorsIBA 12/2023
1	Gemcitabine FDA Link 01/2021
1	NucleosidesIBA 01/2021
1	eribulin FDA Link 01/2021
1	pertuzumabIBA 01/2021
1	taxaneIBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2015
1	Estrogens (Estrogen)FDA Link 12/2014
1	VaccinesIBA 07/2013
1	Monoclonal AntibodiesIBA 07/2013
1	DNA (Deoxyribonucleic Acid)IBA 07/2013
1	Peptides (Polypeptides)IBA 07/2013
1	Proteins (Proteins, Gene)FDA Link 07/2013
1	ErbB Receptors (EGF Receptor)IBA 06/2012
1	Epirubicin (Ellence)FDA LinkGeneric 08/2007
1	Leucovorin (Folinic Acid)FDA Link 08/2007
1	Estrogen ReceptorsIBA 11/2006
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2006
1	Tamoxifen FDA LinkGeneric 11/2006
1	AnthracyclinesIBA 02/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2006
1	Methotrexate (Mexate)FDA LinkGeneric 02/2006
1	Zoledronic Acid (Zometa)FDA Link 01/2006
1	Indicators and Reagents (Reagents)IBA 04/2005
1	Diphosphonates (Bisphosphonates)IBA 02/2004
1	Oncogene Proteins (Oncogene Protein)IBA 12/2001
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2000
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2000
1	sargramostim (Leukine)FDA Link 01/2000
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2000
1	Procarbazine (Matulane)FDA Link 01/2000
1	Vincristine (Oncovin)FDA LinkGeneric 01/2000
1	Prednisone (Sone)FDA LinkGeneric 01/2000
1	Dacarbazine (DIC)FDA LinkGeneric 01/2000
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2000

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 12/2023 - 01/2000
10	Therapeutics 01/2021 - 05/2002
2	Radiotherapy 07/2015 - 02/2006
1	Neoadjuvant Therapy 12/2023
1	Surgical Instruments (Clip) 12/2013
1	Conformal Radiotherapy 12/2013
1	Segmental Mastectomy (Lumpectomy) 12/2013
1	Retreatment 06/2012
1	Adjuvant Chemotherapy 08/2007
1	ELFE regimen 08/2007
1	Transplantation 05/2002
1	Stem Cell Transplantation 12/2001
1	Hematopoietic Stem Cell Transplantation 10/2000